Camber Announces Six New Product Launches
Camber Pharmaceuticals, one of the industry’s fastest growing generic pharmaceutical companies is pleased to announce the addition of six new products to its rapidly expanding product line.
Quinapril HCTZ Naproxen Levetiracetam
– 10/12.5mg/90ct – 250mg/100ct and 500ct – 250mg/ 120ct and 500ct – 1000mg/ 60ct
– 20/12.5mg/90ct – 375mg/ 100ct and 500ct – 500mg/120ct and 500ct
– 20/25mg/90ct – 500mg/ 100ct and 500ct – 750mg/120ct and 500ct
Quinapril Naproxen DR Alfuzosin
– 5mg/90ct – 375mg/100ct – 10mg/100ct
– 10mg/90ct – 500mg/100ct
– 20mg/90ct – 500mg/500ct
– 40mg/90ct
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products from API manufacturing to finished dosage. Camber’s parent company Hetero Drugs of Hyderabad, India employs over 300 scientists at 9 API facilities and has a global presence in over 100 countries.
Recent articles
- Now Available from Camber: Topiramate Extended-Release Capsules, USP
- New Product Launch: Clomiphene Citrate Tablets, USP
- Camber Launches Raltegravir Tablets 400 mg
- Specialty Generics: Where Access Meets Affordability
- Buprenorphine and Naloxone Sublingual Films Added to Portfolio
- Buprenorphine and Naloxone Sublingual Tablets Added to Portfolio





